Skip to content

Pharma4Future: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Pharma4Future

BE 0776.403.737
NACE 64.210, Activities of holding companies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€246,977
2024 · €129,711+€117,266
Equity
€563,772
2024 · €316,795+€246,977
Cash
€32,478
2024 · €25,154+€7,324
Balance sheet total
€5.0m
2024 · €5.0m+€13,642

Largest movements

2024 to 2025
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities
    • Debts after one year -€333,741

      down €333,741 (-9.2%), from €3.6m to €3.3m

    • Reserves +€246,977

      up €246,977 (+80.5%), from €306,795 to €553,772

    • Other debts +€100,230

      up €100,230 (+14.8%), from €678,717 to €778,947

    Income statement
    • Gross operating margin +€187,122

      up €187,122 (+71.9%), from €260,352 to €447,474

    • Taxes +€39,052

      up €39,052 (+90.2%), from €43,308 to €82,360

    • Financial charges +€30,707

      up €30,707 (+51.6%), from €59,517 to €90,223

    From the 2024 result to the 2025 result

    effect on the result

    Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

    Result 2024 €129,711
    Gross operating margin +€187,122
    Other operating charges -€97
    Financial charges -€30,707
    Taxes -€39,052
    Result 2025 €246,977
    raises the resultlowers the result

    Derived cash bridge

    cash 2024 to 2025

    Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

    From operations +€358,367
    Investment -€23,614
    Financing -€327,430
    Cash 2024 €25,154
    Net result for the year +€246,977
    Depreciation +€24,739
    Receivables within one year -€7,444
    Trade debts +€1,929
    Tax, wage and social debts +€931
    Advances received -€8,712
    Other debts +€100,230
    Accrued charges and deferred income -€283
    Investment in fixed assets (net) -€23,614
    Debts after one year -€333,741
    Current portion of long-term debt +€6,311
    Cash 2025 €32,478
    brings cash intakes cash out
    Every line side by side 37 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €5,018,749 €5,032,391 +€13,642 +0.3%
    Fixed assets 21/28 €4,986,298 €4,985,173 -€1,125 0.0%
    Tangible fixed assets 22/27 €616,234 €591,495 -€24,739 -4.0%
    Land and buildings 22 €616,234 €591,495 -€24,739 -4.0%
    Financial fixed assets 28 €4,370,064 €4,393,678 +€23,614 +0.5%
    Current assets 29/58 €32,450 €47,218 +€14,768 +45.5%
    Amounts receivable within one year 40/41 €7,296 €14,740 +€7,444 +102%
    Trade receivables 40 €7,200 €12,100 +€4,900 +68.1%
    Other amounts receivable 41 €96 €2,640 +€2,544 +2,649%
    Cash at bank and in hand 54/58 €25,154 €32,478 +€7,324 +29.1%
    Total equity and liabilities 10/49 €5,018,749 €5,032,391 +€13,642 +0.3%
    Equity 10/15 €316,795 €563,772 +€246,977 +78.0%
    Contributions 10/11 €10,000 €10,000 = 0.0%
    Reserves 13 €306,795 €553,772 +€246,977 +80.5%
    Distributable reserves 133 €306,795 €553,772 +€246,977 +80.5%
    Amounts payable 17/49 €4,701,954 €4,468,619 -€233,335 -5.0%
    Amounts payable after more than one year 17 €3,640,767 €3,307,026 -€333,741 -9.2%
    Financial debts 170/4 €3,640,767 €3,307,026 -€333,741 -9.2%
    Amounts payable within one year 42/48 €1,057,725 €1,158,413 +€100,689 +9.5%
    Current portion of amounts payable after more than one year 42 €346,799 €353,110 +€6,311 +1.8%
    Trade debts 44 €2,561 €4,490 +€1,929 +75.3%
    Suppliers 440/4 €2,561 €4,490 +€1,929 +75.3%
    Advances received on contracts in progress 46 €8,712 €0 -€8,712 -100%
    Taxes, remuneration and social security 45 €20,935 €21,866 +€931 +4.4%
    Taxes 450/3 €20,935 €21,866 +€931 +4.4%
    Other amounts payable 47/48 €678,717 €778,947 +€100,230 +14.8%
    Accrued charges and deferred income 492/3 €3,462 €3,179 -€283 -8.2%
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €24,739 €24,739 = 0.0%
    Other operating charges 640/8 €3,077 €3,174 +€97 +3.2%
    Gross operating margin 9900 €260,352 €447,474 +€187,122 +71.9%
    Operating profit (loss) 9901 €232,536 €419,561 +€187,025 +80.4%
    Financial charges 65/66B €59,517 €90,223 +€30,707 +51.6%
    Recurring financial charges 65 €59,517 €90,223 +€30,707 +51.6%
    Profit (loss) for the period before taxes 9903 €173,019 €329,337 +€156,318 +90.3%
    Income taxes 67/77 €43,308 €82,360 +€39,052 +90.2%
    Profit (loss) for the period 9904 €129,711 €246,977 +€117,266 +90.4%
    Profit (loss) for the period to be appropriated 9905 €129,711 €246,977 +€117,266 +90.4%

    Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.